Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials.
Dongfang WangJohannes Schneider-ThomaSpyridon SiafisAngelika BurschinskiShimeng DongHui WuYikang ZhuJohn M DavisJosef PrillerStefan LeuchtPublished in: Schizophrenia bulletin (2023)
SGA-LAIs effectively treat acute schizophrenia. Some side effects may be less frequent than under oral drugs, but due to the indirect nature of the comparisons, this finding must be confirmed by RCTs comparing LAIs and orals head-to-head.